Washington - Johnson & Johnson, the global maker of medical devices and pharmaceutical products, on Tuesday reported a 0.6% slip in fourth quarter revenues to $18.3bn compared to the same period in 2013.
Analysts said that the stronger dollar helped erode foreign sales by 6.7%, while domestic sales rose 7.4%.
Quarterly net earnings increased by 1.4% to $3.6bn.
For the full year 2014, worldwide sales were up 4.2%, to $74.3bn, compared to 2013. Net earnings were $17.1bn, an increase of 7.7% over 2013, the company said.